Abstract

Delays in treating breast cancer have been associated with a more advanced stage of the disease and a decrease in patient survival rates. The scope of this integrative review was to analyze the main causal factors and types of patient and system delays. The underlying causal factors of delays were compared among studies conducted in developing and developed countries. Of the 53 studies selected, 24 were carried out in developing countries and 29 in developed countries, respectively. Non-attribution of symptoms to cancer, fear of the disease and treatment and low educational level were the most frequent causes of patient delay. Less comprehensive health insurance coverage, older/younger age and false negative diagnosis tests were the three most common causal factors of system delay. The effects of factors such as age were not decisive per se and depended mainly on the social and cultural context. Some factors caused both patient delay and system delay. Studies conducted in developing countries identified more causal factors of patient delay and had a stronger focus on patient delay or the combination of both. Studies conducted in developed countries had a stronger focus on aspects of system delay during treatment and guidance of breast cancer patients in the health care system.

Highlights

  • Breast cancer is the most common type of cancer among women worldwide, with about 1.67 million new cases diagnosed in the year 20121,2.The incidence of breast cancer is still high in developed countries, but the global burden of the disease is progressively shifting to developing countries[1,2]

  • According to Lee Caplan (2014), patient delay (PD) is a delay in seeking medical attention after self-discovering a potential breast cancer symptom, whereas system delay (SD) is a delay within the health care system[10]

  • With exception of one Brazilian study written in Portuguese, a Colombian study written in Spanish and a study carried out in Tunisia written in French, all the other 50 studies were written in English (Table 1)[16,17,18]

Read more

Summary

Introduction

Breast cancer is the most common type of cancer among women worldwide, with about 1.67 million new cases diagnosed in the year 20121,2.The incidence of breast cancer is still high in developed countries, but the global burden of the disease is progressively shifting to developing countries[1,2]. Breast cancer stage represents an important prognostic factor and advanced stage is associated with decreased time of disease-free survival and increased mortality rates[4,5]. Previous studies have shown that care delay associated with increased stage had a negative effect on the survival of breast cancer patients and were more common among patients in developing countries[3,4,8,9]. To reduce SD, health services must fit with the socio-economic and cultural or ethnic background of patients[3,11]. Despite the existence of vast literature about breast cancer care delays only few authors have compared studies conducted at different regions of the world. If care delays and their adjacent causes are different among developing and developed countries

Method
Results and discussion
Method Sampling
10 In-depth-interview Descriptive
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call